Loading provider…
Loading provider…
Internal Medicine Physician in Detroit, MI
NPI: 1366510810Primary Practice Location
HENRY FORD HEALTH HOSPITAL
2799 W Grand Blvd, Detroit, MI
Primary Employer
Henry Ford Health
henryford.com
HQ Phone
Get M.D. Philip's Phone NumberMobile
Get M.D. Philip's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMI State Medical License
2002 - 2027
FL State Medical License
1998 - 2016
MI State Medical License

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Henry Ford Health/Henry Ford Hospital
Residency • Internal Medicine
1996 - 1999
Christian Medical College Ludhiana
Medical School
Until 1990
Mayo Clinic Alix School of Medicine - Rochester
college.mayo.edu
Fellowship • Hematology and Medical Oncology
1999 - 2002
Chemotherapy as Treatment for Acute Myeloid Leukemia (AML)-Induced Facial Nerve Palsy.
Authors: Fana, Michael, Centofanti, Brook, Kuriakose, Philip
Journal: Cureus
Publication Date: 2022-03-31
Authors: Thomson, Julie, Kuriakose, Philip, To, Long, Peters, Michael, Kalus, James
Journal: J Thromb Thrombolysis
Impact of a Pharmacist-Directed Anticoagulation Service on the Quality and Safety of Heparin-Induced Thrombocytopenia Management
Authors: Long To, Jessica Schillig, Brian D. Desmet, Philip Kuriakose, Edward G. Szandzik, James S. Kalus
Publication Date: 2011-02
Lead Sponsor: American Thrombosis and Hemostasis Network
Collaborators: LFB USA, Inc.
Intervention / Treatment: DRUG: coagulation factor VIIa [recombinant]-jncw
Lead Sponsor: Baxalta now part of Shire
Collaborators: Baxalta Innovations GmbH, now part of Shire
Intervention / Treatment: BIOLOGICAL: OBIZUR
Lead Sponsor: Cyclacel Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Decitabine, DRUG: Sapacitabine